Results 191 to 200 of about 12,381 (205)
Some of the next articles are maybe not open access.

Radioimmunotherapy for Waldenstrom's macroglobulinemia

Seminars in Oncology, 2003
Radioimmunotherapy targeting CD20 is a promising novel treatment for lymphoma. Prior trials have established the safe dose of Zevalin ((90)Y-ibritumomab tiuxetan; IDEC Pharmaceuticals) for patients with no more than 25% bone marrow (BM) involvement. Zevalin is expected to be an effective treatment for WM; however, the safe dose has not been defined.
openaire   +2 more sources

Radioimmunotherapy

2021
Majid Assadi, Ali Gholamrezanezhad
openaire   +1 more source

RADIOIMMUNOTHERAPY

Clinical Nuclear Medicine, 2000
openaire   +1 more source

Radioimmunotherapy of Leukemia

2004
John M, Burke, Joseph G, Jurcic
openaire   +2 more sources

RADIOIMMUNOTHERAPY

Clinical Nuclear Medicine, 1999
openaire   +1 more source

Radioimmunotherapy (RIT)

2016
F. F. Knapp, Ashutosh Dash
openaire   +1 more source

Radioimmunotherapy (RIT)

2013
Ning J. Yue   +61 more
openaire   +1 more source

Targeted Radioimmunotherapy

2013
Tod W. Speer   +48 more
openaire   +1 more source

Home - About - Disclaimer - Privacy